Susquehanna International Group
BMY icon

Susquehanna International Group’s Bristol-Myers Squibb BMY Stock Holding History

Susquehanna International Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293M Sell
4,835,000
-1,624,100
-25% -$94.7M 0.03% 391
2025
Q4 		$348M Sell
6,459,100
-1,203,800
-16% -$57.9M 0.04% 359
2025
Q3 		$346M Sell
7,662,900
-17,800
-0.2% -$831K 0.04% 366
2025
Q2 		$356M Buy
7,680,700
+641,500
+9% +$31.5M 0.05% 296
2025
Q1 		$429M Buy
7,039,200
+1,602,300
+29% +$93.4M 0.07% 206
2024
Q4 		$308M Sell
5,436,900
-1,295,200
-19% -$72.4M 0.05% 305
2024
Q3 		$348M Sell
6,732,100
-736,800
-10% -$34.6M 0.06% 263
2024
Q2 		$310M Buy
7,468,900
+2,105,300
+39% +$94.2M 0.06% 249
2024
Q1 		$291M Buy
5,363,600
+225,500
+4% +$11.5M 0.05% 299
2023
Q4 		$264M Sell
5,138,100
-532,200
-9% -$27.9M 0.05% 309
2023
Q3 		$329M Buy
5,670,300
+2,267,200
+67% +$139M 0.07% 224
2023
Q2 		$218M Sell
3,403,100
-924,600
-21% -$62M 0.04% 320
2023
Q1 		$300M Buy
4,327,700
+195,600
+5% +$13.8M 0.06% 249
2022
Q4 		$297M Sell
4,132,100
-256,300
-6% -$19.3M 0.08% 228
2022
Q3 		$312M Sell
4,388,400
-1,724,200
-28% -$125M 0.08% 184
2022
Q2 		$471M Sell
6,112,600
-28,500
-0.5% -$2.17M 0.12% 127
2022
Q1 		$448M Buy
6,141,100
+503,200
+9% +$33.8M 0.08% 183
2021
Q4 		$352M Buy
5,637,900
+655,300
+13% +$38.4M 0.05% 303
2021
Q3 		$295M Sell
4,982,600
-524,600
-10% -$34.5M 0.04% 377
2021
Q2 		$368M Buy
5,507,200
+790,200
+17% +$51.5M 0.05% 302
2021
Q1 		$298M Sell
4,717,000
-227,200
-5% -$14.1M 0.05% 330
2020
Q4 		$307M Sell
4,944,200
-384,200
-7% -$23.6M 0.05% 291
2020
Q3 		$321M Sell
5,328,400
-1,499,900
-22% -$90.3M 0.06% 239
2020
Q2 		$402M Buy
6,828,300
+259,100
+4% +$15.5M 0.1% 167
2020
Q1 		$366M Buy
6,569,200
+526,000
+9% +$32.1M 0.12% 137
2019
Q4 		$388M Sell
6,043,200
-1,729,300
-22% -$99M 0.11% 137
2019
Q3 		$394M Buy
7,772,500
+3,475,500
+81% +$163M 0.13% 122
2019
Q2 		$195M Sell
4,297,000
-1,882,700
-30% -$87.7M 0.07% 226
2019
Q1 		$295M Buy
6,179,700
+258,300
+4% +$12.9M 0.12% 133
2018
Q4 		$308M Buy
5,921,400
+430,100
+8% +$23.1M 0.12% 135
2018
Q3 		$341M Sell
5,491,300
-461,900
-8% -$27.4M 0.11% 135
2018
Q2 		$329M Sell
5,953,200
-1,025,200
-15% -$55.4M 0.11% 140
2018
Q1 		$441M Sell
6,978,400
-1,469,100
-17% -$94.5M 0.16% 87
2017
Q4 		$518M Buy
8,447,500
+800,900
+10% +$50.1M 0.18% 72
2017
Q3 		$487M Buy
7,646,600
+908,400
+13% +$53M 0.19% 77
2017
Q2 		$375M Buy
6,738,200
+514,300
+8% +$28M 0.17% 100
2017
Q1 		$338M Buy
6,223,900
+2,875,300
+86% +$158M 0.17% 95
2016
Q4 		$196M Buy
3,348,600
+712,400
+27% +$38.9M 0.1% 176
2016
Q3 		$142M Sell
2,636,200
-355,400
-12% -$22.8M 0.07% 239
2016
Q2 		$220M Buy
2,991,600
+186,300
+7% +$13.2M 0.12% 138
2016
Q1 		$179M Buy
2,805,300
+1,156,000
+70% +$72.9M 0.1% 168
2015
Q4 		$113M Sell
1,649,300
-1,690,600
-51% -$112M 0.05% 319
2015
Q3 		$198M Buy
3,339,900
+1,530,400
+85% +$97.1M 0.09% 201
2015
Q2 		$120M Sell
1,809,500
-508,900
-22% -$33.5M 0.05% 344
2015
Q1 		$150M Sell
2,318,400
-726,200
-24% -$45.5M 0.07% 253
2014
Q4 		$180M Sell
3,044,600
-767,900
-20% -$43.3M 0.07% 258
2014
Q3 		$195M Buy
3,812,500
+1,921,400
+102% +$96M 0.08% 222
2014
Q2 		$91.7M Sell
1,891,100
-1,708,200
-47% -$84.2M 0.04% 406
2014
Q1 		$187M Buy
3,599,300
+828,200
+30% +$44.1M 0.09% 193
2013
Q4 		$147M Buy
2,771,100
+30,800
+1% +$1.57M 0.07% 234
2013
Q3 		$127M Buy
2,740,300
+1,180,300
+76% +$51.8M 0.07% 244
2013
Q2 		$69.7M Buy
+1,560,000
New +$67.7M 0.04% 407

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's BMY Position: Q1 2026 in Review

Susquehanna International Group reduced its Bristol-Myers Squibb (BMY) stake by 19% in Q1 2026, selling an estimated $8.43M and leaving 600,889 shares worth $36.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1554.

Susquehanna International Group first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $294M in Q4 2019. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Susquehanna International Group held 600,889 shares of Bristol-Myers Squibb worth $36.4M as of Q1 2026.
  • Susquehanna International Group sold 144,605 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.43M.
  • Bristol-Myers Squibb made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1554 holding.
  • Susquehanna International Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • Susquehanna International Group's Bristol-Myers Squibb position peaked at $294M in Q4 2019.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.